News, Articles & Resources
Cancer Research and Cancer Support Articles
Learn how targeted therapy and molecular profiling are advancing personalized cancer treatment. Understand how genetic insights guide therapy decisions to improve outcomes.
Rx To Go achieves ACHC re-accreditation for pharmacy with distinction in oncology.
Some conditions cause your body to overproduce red blood cells or iron. A phlebotomy will remove some of these cells.
Triple-negative breast cancer lacks three common receptors found in many other breast cancers: estrogen, progesterone, and HER2 protein. Learn more.
Bone marrow biopsy and bone marrow aspiration are procedures to collect and examine bone marrow. Learn More.
HER2-positive breast cancer is a type in which the cancer cells make too much of a protein called human epidermal growth factor receptor 2. Learn more.
FCS clinicians share expertise at the FLASCO Fall Oncology Congress to advance cancer care and improve patient outcomes.
In this video John Sodeika discusses his journey to recovery after being diagnosed with advanced gastric cancer.
FCS Top News Updates
October 20, 2026
FCS Leadership Review of Step Therapy Policies Details Troubling Impacts to Cancer Patients
October 19, 2026
FCS Welcomes Kelly Elleson, MD, FACS, Breast and Melanoma Surgical Oncologist
October 15, 2026
FCS Clinical Summit Advances Strategic Priorities, Research Innovation & Excellence in Patient Care
October 14, 2026
FCS Contributes to Two Significant FDA Approvals Advancing Breast and Pancreatic Cancer Care